More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$105.70B
EPS
9.65
P/E ratio
28.5
Price to sales
4.09
Dividend yield
1.277%
Beta
0.760815
Previous close
$270.01
Today's open
$270.72
Day's range
$267 - $277
52 week range
$267 - $392.55
show more
CEO
Kevin A. Lobo
Employees
56000
Headquarters
Portage, MI
Exchange
New York Stock Exchange
Shares outstanding
383573046
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Stryker ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses
Boston, Massachusetts--(Newsfile Corp. - September 11, 2026) - Block & Leviton is investigating Stryker (NYSE: SYK) for potential securities law violations. Investors who have lost money in their Stryker investment should contact the firm to learn more about how they might recover those losses.
Newsfile Corp • Sep 11, 2026

Stryker Corporation (SYK) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Stryker Corporation (“Stryker” or the “Company”) (NYSE: SYK) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN STRYKER CORPORATION (SYK), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email.
Business Wire • Sep 10, 2026

Securities Fraud Investigation Into Stryker Corporation (SYK) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Stryker Corporation (“Stryker” or the “Company”) (NYSE: SYK) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON STRYKER CORPORATION (SYK), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On Ju.
Business Wire • Sep 10, 2026

Securities Fraud Investigation Into Stryker Corporation (SYK) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Stryker Corporation (“Stryker” or the “Company”) (NYSE: SYK) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON STRYKER CORPORATION (SYK), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On July 30, 2026, Stryker reported second quarter 2026 results. Among.
Business Wire • Sep 9, 2026

Stryker Corporation (SYK) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Stryker Corporation (SYK) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Seeking Alpha • Sep 8, 2026

SYK ALERT: Stryker Investigated for Securities Fraud by Block & Leviton; Investors Should Contact the Firm
Block & Leviton is investigating Stryker Corp. (NYSE: SYK) for possible securities fraud. Stryker investors with losses should contact Block & Leviton LLP.
GlobeNewsWire • Sep 8, 2026

Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference
Portage, Michigan, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor, as previously reported.
GlobeNewsWire • Sep 4, 2026

Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money
Both Intuitive Surgical and Stryker just posted their fifth straight earnings beat, and Wall Street is cheering for both. But a structural difference buried inside their business models quietly separates a compounder from a cyclical recovery story.
24/7 Wall Street • Sep 4, 2026

Stryker Launches FDA-Cleared Apple Vision Pro Surgical App
SYK's FDA-cleared SportSuite Vision brings Apple Vision Pro into hip arthroscopy, strengthening its digital surgery push and Sports Medicine portfolio.
Zacks Investment Research • Sep 3, 2026

Stryker to Acquire ZuriMED to Expand Its Shoulder Care Portfolio
SYK's planned ZuriMED acquisition adds the FiberLocker System, aiming to strengthen its shoulder portfolio and rotator cuff care capabilities.
Zacks Investment Research • Sep 1, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Stryker Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.